slotkoers
Korea S.E.
00:00:00 14-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
5.640
KRW
|
-1,91%
|
|
+1,81%
|
+13,94%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
76.121
|
82.062
|
145.429
|
78.193
|
51.626
|
35.741
|
Bedrijfswaarde
1 |
77.195
|
103.090
|
157.584
|
92.940
|
81.227
|
67.910
|
K/w-verhouding
|
11,4
x
|
200
x
|
-12,9
x
|
-7,1
x
|
-56,6
x
|
-1,97
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1,39
x
|
1,6
x
|
2,89
x
|
1,62
x
|
0,84
x
|
0,57
x
|
Bedrijfswaarde/omzet
|
1,41
x
|
2,01
x
|
3,13
x
|
1,92
x
|
1,33
x
|
1,08
x
|
Bedrijfswaarde/EBITDA
|
7,99
x
|
31,6
x
|
-22,2
x
|
-14,5
x
|
15,4
x
|
-6,29
x
|
Bedrijfswaarde/FCF
|
-9,78
x
|
-7,34
x
|
-41,2
x
|
11,8
x
|
-6,08
x
|
-9,02
x
|
FCF Yield
|
-10,2%
|
-13,6%
|
-2,43%
|
8,47%
|
-16,5%
|
-11,1%
|
Price to Book
|
1,35
x
|
1,41
x
|
2,13
x
|
1,47
x
|
1,06
x
|
1,18
x
|
Aantal aandelen (in duizenden)
|
5.745
|
5.904
|
7.904
|
7.704
|
7.220
|
7.220
|
Referentieprijs
2 |
13.250
|
13.900
|
18.400
|
10.150
|
7.150
|
4.950
|
Datum van publicatie
|
19-03-19
|
16-03-20
|
23-03-21
|
23-03-22
|
23-03-23
|
21-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
54.662
|
51.264
|
50.379
|
48.304
|
61.293
|
63.169
|
EBITDA
1 |
9.659
|
3.266
|
-7.084
|
-6.389
|
5.266
|
-10.792
|
Bedrijfsresultaat (EBIT)
1 |
7.768
|
791,3
|
-10.832
|
-10.615
|
1.271
|
-14.682
|
Operationele Marge
|
14,21%
|
1,54%
|
-21,5%
|
-21,97%
|
2,07%
|
-23,24%
|
Resultaat voor belastingen (EBT)
1 |
6.854
|
586,3
|
-12.084
|
-14.477
|
943,5
|
-14.404
|
Nettowinst (verlies)
1 |
5.828
|
411,2
|
-9.322
|
-11.109
|
-932
|
-18.156
|
Nettomarge
|
10,66%
|
0,8%
|
-18,5%
|
-23%
|
-1,52%
|
-28,74%
|
WPA
2 |
1.158
|
69,53
|
-1.431
|
-1.430
|
-126,3
|
-2.514
|
Free Cash Flow
1 |
-7.896
|
-14.054
|
-3.824
|
7.871
|
-13.368
|
-7.528
|
FCF-marge
|
-14,44%
|
-27,41%
|
-7,59%
|
16,3%
|
-21,81%
|
-11,92%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
19-03-19
|
16-03-20
|
23-03-21
|
23-03-22
|
23-03-23
|
21-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
1.074
|
21.028
|
12.155
|
14.747
|
29.601
|
32.169
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
0,1111
x
|
6,439
x
|
-1,716
x
|
-2,308
x
|
5,622
x
|
-2,981
x
|
Free Cash Flow
1 |
-7.896
|
-14.054
|
-3.824
|
7.871
|
-13.368
|
-7.528
|
ROE (netto-inkomsten/eigen vermogen)
|
14,1%
|
0,71%
|
-14,7%
|
-18,2%
|
-1,82%
|
-46%
|
ROA (netto-inkomsten/totale activa)
|
6,66%
|
0,54%
|
-6,99%
|
-6,14%
|
0,69%
|
-8,87%
|
Totale activa
1 |
87.464
|
75.720
|
133.307
|
181.048
|
-135.804
|
204.737
|
Nettoactief per aandeel
2 |
9.792
|
9.833
|
8.650
|
6.925
|
6.733
|
4.196
|
Cashflow per aandeel
2 |
2.131
|
880,0
|
197,0
|
2.733
|
833,0
|
910,0
|
Capex
1 |
5.479
|
16.017
|
7.844
|
7.168
|
3.366
|
2.263
|
Capex/omzet
|
10,02%
|
31,24%
|
15,57%
|
14,84%
|
5,49%
|
3,58%
|
Datum van publicatie
|
19-03-19
|
16-03-20
|
23-03-21
|
23-03-22
|
23-03-23
|
21-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +13,94% | 29,45 mln. | | +15,93% | 9,25 mld. | | +42,06% | 4,45 mld. | | -22,01% | 4,43 mld. | | +8,28% | 4,03 mld. | | +11,22% | 2,24 mld. | | -26,61% | 2,18 mld. | | +11,64% | 2,02 mld. | | -42,69% | 1,79 mld. | | -0,50% | 1,64 mld. |
Specialiteit & Geavanceerde Farmaceutische Producten
|